Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Autologous tumor-derived immunoglobulin idiotype coupled to keyhole limpet haemocyanin

EU orphan designation number: EU/3/06/394   
Active ingredient: Autologous tumor-derived immunoglobulin idiotype coupled to keyhole limpet haemocyanin
Indication: Treatment of follicular lymphoma
Sponsor: Biovest Europe Limited
Evershed House, 70 Great Bridgewater St., Manchester M1 5ES, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
04/09/2006 Centralised Orphan - Designation EMEA/OD/040/06 (2006)3951 of 28/08/2006
18/05/2011 Centralised Orphan - Transfer of orphan designation EMEA/OD/040/06/T/01 (2011)3479 of 13/05/2011
29/09/2011 Centralised Orphan - Transfer of orphan designation EMEA/OD/040/06/T/02 (2011)7049 of 27/09/2011